Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etravirine in Friedreich Ataxia
NCT04273165Phase 2Completed
- Sponsor
- IRCCS Eugenio Medea
- Start
- Sep 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etravirine in Friedreich ataxia (FA), sponsored by IRCCS Eugenio Medea. Started Sep 2020; status: completed.
02
Drugs
etravirine
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT04273165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273165.